Singapore-Based Biotech Startup Cargene Therapeutics Received $13 Million From Its Us-Based Affiliate Last Week.
Singapore-Based Biotech Startup Cargene Therapeutics Received $13 Million From Its Us-Based Affiliate Last Week.
02/08/22, 2:02 AM
Money raised
$13 million
Singapore-based biotech startup Cargene Therapeutics received $13 million from its US-based affiliate last week.
Company Info
Additional Info
The firm, which has offices in Singapore, Shanghai and Boston, had raised $19.2 million in funding in December from a group of investors led by China-based venture capital firm BioTrack Capital. Singapore-based biotech startup Cargene Therapeutics received $13 million from its US-based affiliate last week.